A new 20mg formulation of doxycycline hyclate [`Periostat'; CollaGenex Pharmaceuticals] has been approved in Canada

Source: Inpharma, Volume 1, Number 1382, 2003 , pp. 18-18(1)

Publisher: Adis International

Keywords: CollaGenex-Pharmaceuticals; Development-status; Doxycycline-hyclate, therapeutic use; Periodontitis, treatment; Product-approvals

Language: English

Document Type: Short communication

Links for this article